Citigroup’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.7M | Buy |
77,000
+37,000
| +93% | +$5.18M | ﹤0.01% | 1429 |
|
|
2025
Q4 | $4.91M | Hold |
40,000
| – | – | ﹤0.01% | 2021 |
|
|
2025
Q3 | $4.44M | Hold |
40,000
| – | – | ﹤0.01% | 2053 |
|
|
2025
Q2 | $4.43M | Sell |
40,000
-97,700
| -71% | -$10.4M | ﹤0.01% | 1994 |
|
|
2025
Q1 | $15.4M | Sell |
137,700
-40,000
| -23% | -$4.13M | 0.01% | 1106 |
|
|
2024
Q4 | $16.4M | Sell |
177,700
-104,900
| -37% | -$9.44M | 0.01% | 1068 |
|
|
2024
Q3 | $23.7M | Sell |
282,600
-97,600
| -26% | -$7.45M | 0.01% | 859 |
|
|
2024
Q2 | $26.1M | Buy |
380,200
+168,200
| +79% | +$11.2M | 0.02% | 778 |
|
|
2024
Q1 | $15.5M | Buy |
212,000
+1,200
| +0.6% | +$92.3K | 0.01% | 1014 |
|
|
2023
Q4 | $17.1M | Sell |
210,800
-21,000
| -9% | -$1.63M | 0.01% | 943 |
|
|
2023
Q3 | $17.4M | Buy |
231,800
+70,800
| +44% | +$5.45M | 0.01% | 843 |
|
|
2023
Q2 | $12.4M | Buy |
161,000
+20,000
| +14% | +$1.6M | 0.01% | 1042 |
|
|
2023
Q1 | $11.7M | Buy |
141,000
+30,000
| +27% | +$2.48M | 0.01% | 1084 |
|
|
2022
Q4 | $9.53M | Sell |
111,000
-421,700
| -79% | -$33.4M | 0.01% | 1159 |
|
|
2022
Q3 | $32.9M | Buy |
532,700
+111,100
| +26% | +$7.01M | 0.02% | 543 |
|
|
2022
Q2 | $26.1M | Buy |
421,600
+213,400
| +102% | +$13.2M | 0.02% | 673 |
|
|
2022
Q1 | $12.4M | Sell |
208,200
-1,335,500
| -87% | -$85.4M | 0.01% | 1187 |
|
|
2021
Q4 | $112M | Buy |
1,543,700
+35,000
| +2% | +$2.41M | 0.06% | 285 |
|
|
2021
Q3 | $105M | Buy |
1,508,700
+130,000
| +9% | +$9.13M | 0.06% | 276 |
|
|
2021
Q2 | $94.9M | Sell |
1,378,700
-407,100
| -23% | -$27.2M | 0.06% | 311 |
|
|
2021
Q1 | $115M | Sell |
1,785,800
-211,100
| -11% | -$13.6M | 0.07% | 242 |
|
|
2020
Q4 | $116M | Buy |
1,996,900
+434,600
| +28% | +$26.2M | 0.07% | 259 |
|
|
2020
Q3 | $98.7M | Buy |
1,562,300
+53,900
| +4% | +$3.74M | 0.06% | 246 |
|
|
2020
Q2 | $116M | Sell |
1,508,400
-303,200
| -17% | -$23.2M | 0.09% | 189 |
|
|
2020
Q1 | $135M | Buy |
1,811,600
+1,076,600
| +146% | +$74.4M | 0.12% | 138 |
|
|
2019
Q4 | $47.8M | Buy |
735,000
+272,600
| +59% | +$17.8M | 0.03% | 528 |
|
|
2019
Q3 | $29.3M | Sell |
462,400
-209,500
| -31% | -$13.7M | 0.02% | 708 |
|
|
2019
Q2 | $45.4M | Buy |
671,900
+133,500
| +25% | +$8.78M | 0.04% | 480 |
|
|
2019
Q1 | $35M | Sell |
538,400
-235,900
| -30% | -$15.7M | 0.03% | 543 |
|
|
2018
Q4 | $48.4M | Buy |
774,300
+89,100
| +13% | +$6.23M | 0.05% | 407 |
|
|
2018
Q3 | $52.9M | Sell |
685,200
-99,600
| -13% | -$7.52M | 0.05% | 365 |
|
|
2018
Q2 | $55.6M | Sell |
784,800
-417,400
| -35% | -$29.5M | 0.05% | 329 |
|
|
2018
Q1 | $90.6M | Sell |
1,202,200
-498,700
| -29% | -$39.6M | 0.07% | 218 |
|
|
2017
Q4 | $122M | Sell |
1,700,900
-46,700
| -3% | -$3.55M | 0.1% | 188 |
|
|
2017
Q3 | $142M | Buy |
1,747,600
+941,700
| +117% | +$72M | 0.12% | 128 |
|
|
2017
Q2 | $57M | Sell |
805,900
-266,300
| -25% | -$17.7M | 0.05% | 300 |
|
|
2017
Q1 | $72.8M | Sell |
1,072,200
-198,300
| -16% | -$13.9M | 0.06% | 251 |
|
|
2016
Q4 | $91M | Sell |
1,270,500
-382,500
| -23% | -$28.4M | 0.08% | 226 |
|
|
2016
Q3 | $131M | Buy |
1,653,000
+362,400
| +28% | +$29.4M | 0.12% | 132 |
|
|
2016
Q2 | $108M | Buy |
1,290,600
+532,900
| +70% | +$47.3M | 0.11% | 159 |
|
|
2016
Q1 | $69.6M | Sell |
757,700
-1,083,800
| -59% | -$97.7M | 0.08% | 235 |
|
|
2015
Q4 | $186M | Buy |
1,841,500
+348,900
| +23% | +$36.3M | 0.19% | 86 |
|
|
2015
Q3 | $147M | Sell |
1,492,600
-92,100
| -6% | -$10.2M | 0.14% | 109 |
|
|
2015
Q2 | $186M | Buy |
1,584,700
+96,800
| +7% | +$10.6M | 0.16% | 86 |
|
|
2015
Q1 | $146M | Sell |
1,487,900
-2,053,600
| -58% | -$209M | 0.14% | 114 |
|
|
2014
Q4 | $334M | Buy |
3,541,500
+1,073,600
| +44% | +$111M | 0.3% | 33 |
|
|
2014
Q3 | $263M | Buy |
2,467,900
+423,000
| +21% | +$41.4M | 0.23% | 51 |
|
|
2014
Q2 | $170M | Buy |
2,044,900
+30,100
| +1% | +$2.34M | 0.16% | 95 |
|
|
2014
Q1 | $143M | Sell |
2,014,800
-74,600
| -4% | -$5.85M | 0.15% | 105 |
|
|
2013
Q4 | $157M | Buy |
2,089,400
+660,400
| +46% | +$46M | 0.14% | 108 |
|
|
2013
Q3 | $89.8M | Sell |
1,429,000
-80,000
| -5% | -$4.78M | 0.08% | 211 |
|
|
2013
Q2 | $77.3M | Buy |
+1,509,000
| New | +$78.7M | 0.08% | 200 |
|
Other funds holding GILD
VCM
VPM
Citigroup's GILD Position: Q1 2026 in Review
Citigroup increased its Gilead Sciences (GILD) stake by 30% in Q1 2026, buying an estimated $73.4M and bringing the position to 2,300,271 shares worth $321M. The position accounts for 0.14% of the portfolio, ranked #145.
Citigroup first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Citigroup held 2,300,271 shares of Gilead Sciences worth $321M as of Q1 2026.
- Citigroup bought 524,041 Gilead Sciences shares in Q1 2026, an estimated $73.4M.
- Gilead Sciences made up 0.14% of Citigroup's portfolio in Q1 2026, its #145 holding.
- Citigroup first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.